BARCLAYS PLC - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 41 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$0
-100.0%
163
-96.9%
0.00%
Q1 2023$4
-98.3%
5,290
-98.8%
0.00%
Q4 2022$230
-99.9%
452,2500.0%0.00%
Q3 2022$289,000
-38.0%
452,2500.0%0.00%
Q2 2022$466,000
-45.9%
452,250
-1.2%
0.00%
-100.0%
Q1 2022$861,000457,9670.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,156,200$10,672,0001.77%
ACT CAPITAL MANAGEMENT, LLC 239,000$2,207,0001.13%
EcoR1 Capital, LLC 2,358,804$21,772,0000.81%
Redmile Group, LLC 3,919,235$36,175,0000.54%
Boxer Capital, LLC 1,501,058$13,855,0000.49%
Baker Brothers Advisors 3,821,740$35,275,0000.16%
Sio Capital Management, LLC 38,312$354,0000.09%
Highland Private Wealth Management 46,999$434,0000.06%
PERSONAL CFO SOLUTIONS, LLC 23,710$219,0000.04%
Point72 Asset Management, L.P. 883,102$8,151,0000.04%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders